CSTL: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net revenues from external customers	257,219	-
Personnel costs	156,614	-
Organizational and marketing costs	39,983	-
Inventory usage	16,316	-
Clinical studies and publication costs	6,191	-
Professional services	8,398	-
Other segment items	51,543	-
Net (loss) income	-21,826	-21,325
Depreciation and amortization	36,994	33,178
Stock-based compensation expense	34,487	22,387
Change in fair value of equity securities	3,321	-240
Deferred income taxes	-5,321	-5,437
Accretion of discounts on marketable investment securities	3,511	2,606
Other	-282	-219
Accounts receivable	-604	1,307
Prepaid expenses and other current assets	4,535	4,696
Inventory	538	231
Operating lease assets	-1,016	-664
Other assets	54	13
Accounts payable	3,095	1,689
Operating lease liabilities	-1,066	-869
Accrued compensation	-792	-7,582
Other accrued and current liabilities	1,902	474
Net cash provided by operating activities	37,416	14,785
Purchases of marketable investment securities	151,306	92,832
Proceeds from maturities of marketable investment securities	135,200	80,300
Purchases of debt securities classified as held-to-maturity	5,569	5,569
Asset acquisition, net of cash and cash equivalents acquired	18,726	18,726
Purchases of property and equipment	28,837	14,003
Proceeds from sale of property and equipment	40	21
Net cash used in investing activities	-69,198	-50,809
Proceeds from exercise of common stock options	114	37
Payment of employees taxes on vested restricted stock units	4,289	3,104
Proceeds from contributions to the employee stock purchase plan	1,702	1,482
Repayment of principal portion of finance lease liabilities	88	57
Proceeds from lease incentives received	190	190
Proceeds from issuance of term debt	0	0
Net cash (used in) provided by financing activities	-2,371	-1,452
Net change in cash and cash equivalents	-34,153	-37,476
Cash and cash equivalents at beginning of period	119,709	-
Cash and cash equivalents at end of period	85,556	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

CSTL: the cashflow